Florida's regulatory environment is defined by the Board of Medicine, FDUTPA, and an AG office that has been active on healthcare marketing - particularly in the fast-growing med spa, weight-loss, and regen categories.
State-level overview
Florida is a healthcare practice destination - particularly for regen medicine, aesthetic surgery, and concierge medicine - and the regulatory environment reflects that. The Florida Board of Medicine (FBM) enforces specific advertising rules under F.A.C. 64B8, which include physician qualification disclosure, specialty claim rules, and deceptive-advertising prohibitions. FDUTPA provides state-AG and private enforcement over deceptive practices. Florida has been a particularly active jurisdiction for enforcement against stem cell and regenerative medicine marketing, given the volume of such practices in the state.
The FBM enforces F.A.C. 64B8-11 and related advertising rules. Specific focus areas include the 'board-certified' rule (requires ABMS or equivalent), specialty-claim accuracy, and supervision requirements in aesthetic practices. The FBM has also been active on cosmetic surgery marketing specifically - including handling of complications and the marketing of medical tourism.
FDUTPA gives the Florida AG consumer-protection authority over deceptive healthcare marketing. Recent enforcement has included stem cell clinic marketing, telehealth weight-loss advertising, and aesthetic practice package pricing. FDUTPA also permits private action, creating parallel class-action exposure.
Enforcement focus
Florida has a high concentration of regen medicine practices, and the state AG has taken parallel state action on marketing that has also drawn FDA federal enforcement. Marketing claims about disease treatment, FDA approval, and outcome guarantees are the primary triggers.
Florida is a medical-tourism market, particularly for aesthetic surgery. Marketing to out-of-state and international patients requires disclosure of Florida-specific licensure, supervision arrangements for post-op care, and complications handling.
Florida's telehealth-friendly environment has produced substantial weight-loss practice growth - and corresponding state AG attention to marketing that minimizes clinical evaluation or misrepresents medication options.
Florida Board of Medicine enforces specific rules on 'board-certified' language - requiring ABMS or Florida-recognized equivalent certification. Non-ABMS board certification claims must be qualified.
Patterns we flag in Florida
Stem cell marketing with disease-treatment claims
Why: Florida has parallel state-level enforcement on patterns that also trigger FDA action.
Aesthetic surgery marketing without clear Florida-licensure disclosure
Why: Medical tourism context makes licensure disclosure a state-specific concern.
'Board-certified' without ABMS-or-equivalent qualifier
Why: FBM specifically enforces this pattern.
Compounded GLP-1 marketed as brand-name equivalent
Why: Florida AG has initiated enforcement on this pattern under FDUTPA.
Outcome guarantees in aesthetic marketing
Why: Common FDUTPA private-action and AG-action basis.
By specialty
By specialty in Florida
Specialty rules stack on top of state rules. Find the specialty-specific framework that applies to your practice.
Disclaimer
This summary reflects general patterns in Florida healthcare marketing enforcement; it is not legal advice. For state-specific guidance on your practice, consult a Florida-licensed healthcare marketing attorney.
RegenCompliance applies federal FDA and FTC rules plus the most-enforced state patterns automatically. Florida-specific language is part of the rule set.
Other state guides
See allCalifornia healthcare marketing sits under the strictest state-level enforcement environment in the country - Medical Board of California rules, Business & Professions Code §17500 false advertising authority, and active AG consumer protection.
Read state guideTexas has an active Medical Board with specific rules for medical advertising, and the DTPA gives consumers and the state AG independent enforcement authority over deceptive healthcare marketing.
Read state guideNew York's healthcare marketing environment is defined by OPMC, an aggressive AG office, and the state's particularly strict corporate-practice-of-medicine rules - each of which shapes how practices can advertise.
Read state guide